Tumorad is under clinical development by Spago Nanomedical and currently in Phase II for Metastatic Breast Cancer.
The Brighterside of News on MSN12 小时
FDA approved drug achieves 100% remission for rectal cancer
The battle against rectal cancer has entered an extraordinary new phase with the advent of immunotherapy, offering hope to ...
Dr Meghan Martin, a pediatric emergency doctor and mother of four from Florida told her 1.6 million Instagram followers the ...
Medically reviewed by Jennifer Steinhoff, MD Shoulder blade pain is discomfort in or around your shoulder blades. It usually ...
Cilag’s Rybrevant in combo with Lazcluze for first-line treatment of patients with EGFR-mutated advanced NSCLC: Beerse, Belgium Tuesday, Dec ...